纤溶酶

蚯蚓纤溶酶经DEAE-Sepharose离子交换柱层析，可分离为9个纤溶活力不同的组分。

Earthworm fibrinolysin is able to be isolated 9 components with different fibrinolytic activities by DEAE Sepharose Fast Flow ionexchange chromatography .

蚯蚓纤溶酶的分离纯化工艺研究

Studies on the technology for separation and purification of earthworm fibrinolysin

阿罗洛尔对不稳定型心绞痛患者高敏C反应蛋白和纤溶酶原激活物抑制剂-1含量的影响

Effect of Arotinolol on High-sensitive C-reactive Protein and Plasminogen Activator Inhibitor-1 in Patients with Unstable Angina

组织型纤溶酶原激活物基因的DNA改组

DNA family shuffling of tissue-type plasminogen activator genes

血清胆固醇水平与血浆纤维蛋白原水平和纤溶酶原激活物抑制剂-1活性呈显著的正相关性（P＜0.05）。

Serum cholesterol level was also positively correlated with plasma fibrinogen level and PAI-1 activity ( P0.05 ) .

根据已经测得的华根霉纤溶酶蛋白N端氨基酸序列，设计合理的简并性PCR引物。

According the N-terminal amino acid sequence of fibrinolytic enzyme protein , generate primers were designed .

RT-PCR检测胃癌组织中尿激酶型纤溶酶原激活剂mRNA水平表达

Expression of Urokinase-type Plasminogen Activator mRNA in Gastric Cancer Tissues

关节盘前移位对关节滑膜尿激酶型纤溶酶原激活剂及其1型抑制剂mRNA表达的影响

Effect of Disc Displacement on mRNA Expression of Urokinase Plasminogen Activator and Its Inhibitor - 1 in Synovial Tissues

蚯蚓纤溶酶PI（239）基因在杆状病毒中的表达

Expression of Lumbrukinase PI_ ( 239 ) Gene in the Insect Cell using Baculovirus Expression Vector System

结论：CK纤溶酶有望开发成为一种新型口服溶栓药物。

Conclusion : CK fibrinolytic enzyme might be developed as a new thrombolytic medicine .

IgA肾病患者纤溶酶原激活物的变化及临床意义

The changes of plasminogen activators in patients with IgA nephropathy and their clinical significance

EGF对小鼠角质形成细胞中组织型纤溶酶原激活剂表达的调节

Regulation of tissue plasminogen activator expression by EGF in epidermal keratinocytes of mouse

ST段抬高性心肌梗死蛇毒纤溶酶治疗过程内皮祖细胞的变化

Alterations of peripheral blood endothelial progenitor cells from patients with ST elevation myocardial infarction after snake venom fibrinolytic enzyme therapy

目的：了解5／6肾切除大鼠尿纤溶酶原激活物（PA）排泄量的动态变化。

Objective : to observe the urinary plasminogen activator ( PA ) excretion in5 / 6 nephrectomized rats .

方法：采用纤维蛋白原平板溶环法，检测尿中纤溶酶原激活物PA的活性；

Method : Fibrin plate method was applied to examine activity of urinary plasminogen activator ( PA ) .

MCF-7细胞中组织型纤溶酶原激活剂乳腺特异性表达载体的瞬时表达

Transient expression of tissue-type plasminogen activator in mammary carcinoma cell line MCF-7

Ⅰ型纤溶酶原激活物抑制物在IgA肾病肾小管间质损伤中的作用研究

Role of type I plasminogen activator inhibitor in mediating renal tubulointerstitial injury of patients with IgA nephropathy

组织型纤溶酶原激活剂（t-PA）及其突变体的表达研究进展

Progresses in the Expression of Tissue-Type Plasminogen Activator and Its Mutants

可溶性尿激酶型纤溶酶原激活物受体在RA患者血浆和滑液的水平及其临床意义

Detection and significance of soluble urokinase-type plasminogen activator receptor in plasma and synovial fluid of patients with rheumatoid arthritis

野生型组织型纤溶酶原激活剂（t-PA）工程细胞株生物学特性分析

The analysis of biological characteristics for the wild-type t-PA engineering cell lines

组织型纤溶酶原激活剂（t-PA）、纤溶酶原激活剂抑制剂（PAI）均是体内纤溶系统的重要组成部分。

PAI and t-PA are important constituents of fibrinolytic system in human body .

尿激酶型纤溶酶原激活剂（uPA）系统在子宫内膜癌中的研究进展

Study On uPA System in the Carcinoma of Endometrium

SQ复方能降低纤溶酶原激活物（t-PA）的含量。

SQ complex prescription decreased the contends of tissue plasminogenactivator ( t-PA ) .

目的：探索CK纤溶酶的分离纯化方法及观察其体外溶栓作用。

Objective : To explore the isolation methods of the CK fibrinolytic enzyme and to observe its thrombolytic activity in vitro .

肝X受体激动剂对高脂载脂蛋白E基因缺陷小鼠动脉壁一氧化氮合酶、增殖细胞核抗原和纤溶酶原激活物抑制剂1表达的影响

The Effects of Liver X Receptor Agonists on the Expressions of Nitric Oxide Synthase , Proliferating Cell Nuclear Antigen and Plasminogen Activator Inhibitor-1 in the Artery of Apolipoprotein E-Deficient Mice

目的观察尿激酶（UK）治疗急性脑梗死的疗效及血浆纤溶酶的活性变化。

Objective To observe the clinical and fibrinolytic effect o f Urokinase ( UK ) therapy in the acute cerebral infarction , and alteration of D-dimer concentrations and plasmin activity .

尿激酶型纤溶酶原uPA和P~（27）蛋白在乳腺癌中的表达及其意义

Expression and clinical significance of uPA and P ~ ( 27 ) protein in breast cancer

本文建立了组织型纤溶酶原激活剂（t-PA）活力的发光固相测定方法。

A luminescence solid phase assay for tissue type plasminogen activator ( t-PA ) was developed .

单链尿激酶型纤溶酶原激活剂Kringle结构域催化功能探讨

Catalysis-related Function of Kringle Domain of Single Chain Urokinase-type Plasminogen Activator

实验性颈动脉粥样硬化模型中血栓素B2和6-酮-前列腺素F1α与抗凝血酶Ⅲ和纤溶酶原活性的改变

The Changes of Thromboxane B2 , 6-ket-prostaglandin F1 α, Antithrombin ⅲ and Plasminogen in a Experimental Carotid Atherosclerotic Model of Rabbits